|
Jan 12
|
FDA Finds No Link Between Obesity Drugs and Suicidal Thoughts
|
|
Jan 11
|
Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights
|
|
Jan 11
|
UPDATE 1-Weight loss drug windfall attracts pharma companies
|
|
Jan 11
|
Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza
|
|
Jan 11
|
Drugmakers plot way into obesity market with deals and development
|
|
Jan 10
|
Dogs of the Dow: January’s Top 3 Picks to Buy for Big Gains
|
|
Jan 10
|
JPM's annual healthcare conference: Here's what's next for GLP-1s and the weight loss market
|